Skip to content
value.today

Iota Biosciences, Inc.

Total raised
$15 M
1 round on record
Latest round
$15 M
May 2018
First round on record
May 2018
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Iota Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2018$15 MNo. 1$10 to $50 million

Iota Biosciences, Inc.: Raise no. 1, May 2018

Investors in this round

17 investors had bought by the notice of May 21, 2018: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jose Carmena · Executive Officer, Director
  • Michel Maharbiz · Executive Officer, Director
  • Patrick Zhang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michel Maharbiz, Chief Executive Officer. Newest notice filed May 21, 2018. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Iota Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).

    SEC Form D · May 2018

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · May 2018

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Iota Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Iota Biosciences, Inc.
NameRoleNamed in
Jose CarmenaExecutive officerMay 2018
Michel MaharbizExecutive officerMay 2018
Jose CarmenaDirectorMay 2018
Michel MaharbizDirectorMay 2018
Patrick ZhangDirectorMay 2018